SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-088529
Filing Date
2024-07-31
Accepted
2024-07-31 16:02:20
Documents
2
Period of Report
2024-07-30

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1610
2 EX-24.1 mura-ex24_1.htm EX-24.1 10241
  Complete submission text file 0000950170-24-088529.txt   13445
Mailing Address C/O CELGENE CORP. 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Golumbeski George (Reporting) CIK: 0001586660 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41837 | Film No.: 241161824

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Issuer) CIK: 0001971543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)